Neumora Therapeutics, Inc. NMRA 深 沪
等待开盘 12-24 09:30:00 美东时间
1.75
-0.060
-3.31%
华盛通- 最 高1.91
- 今 开1.86
- 成交量 163.27万股
- 最 低 1.69
- 昨 收 1.81
- 总市值 2.84亿
- 52周最高 3.25
- 市盈率 静 --
- 换手率 1.01%
- 52周最低 0.611
- 委 比 -58.65%
- 总股本 1.62亿
- 历史最高 21.00
- 量 比 1.69
- 振 幅 12.15%
- 历史最低 0.611
- 每 手 1
- 风险率 1.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why ZIM Integrated Shipping Services Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Shares of ZIM Integrated Shipping Services Ltd (NYSE:ZIM) rose sharply in pre-m...
12-23 18:16
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
12-02 09:50
Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline
RBC upgrades Neumora, citing strong early NLRP3 obesity data and growing pipeline momentum ahead of key 2026 readouts.
12-02 02:45
RBC Capital Upgrades Neumora Therapeutics to Outperform, Raises Price Target to $7
RBC Capital analyst Brian Abrahams upgrades Neumora Therapeutics (NASDAQ:NMRA) from Sector Perform to Outperform and raises the price target from $4 to $7.
12-01 19:33
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
11-18 15:28
Stifel Maintains Hold on Neumora Therapeutics, Raises Price Target to $3
Stifel analyst Paul Matteis maintains Neumora Therapeutics (NASDAQ:NMRA) with a Hold and raises the price target from $2 to $3.
11-17 21:52
Neumora Therapeutics shares are trading lower after the company reported worse-than-expected Q3 EPS results.
Neumora Therapeutics shares are trading lower after the company reported worse-...
11-06 21:55
Neumora Therapeutics Q3 EPS $(0.35) Misses $(0.33) Estimate
Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.33) by 4.79 percent. This is a 22.22 percent increase over losses of $(0.45) per share
11-06 20:22
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
10-28 10:08
